Annual Working Capital
$134.76 M
-$56.10 M-29.39%
31 December 2023
Summary:
Adaptimmune Therapeutics annual working capital is currently $134.76 million, with the most recent change of -$56.10 million (-29.39%) on 31 December 2023. During the last 3 years, it has fallen by -$224.31 million (-62.47%). ADAP annual working capital is now -62.47% below its all-time high of $359.08 million, reached on 31 December 2020.ADAP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$180.76 M
+$9.06 M+5.28%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly working capital is currently $180.76 million, with the most recent change of +$9.06 million (+5.28%) on 30 September 2024. Over the past year, it has increased by +$36.53 million (+25.33%). ADAP quarterly working capital is now -56.91% below its all-time high of $419.53 million, reached on 30 June 2020.ADAP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.4% | +25.3% |
| 3 y3 years | -62.5% | -30.3% |
| 5 y5 years | -34.8% | +65.0% |
ADAP Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.5% | at low | -48.8% | +50.0% |
| 5 y | 5 years | -62.5% | +56.4% | -56.9% | +109.8% |
| alltime | all time | -62.5% | +5800.9% | -56.9% | >+9999.0% |
Adaptimmune Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $180.76 M(+5.3%) |
| June 2024 | - | $171.70 M(+42.5%) |
| Mar 2024 | - | $120.49 M(-10.6%) |
| Dec 2023 | $134.76 M(-29.4%) | $134.76 M(-6.6%) |
| Sept 2023 | - | $144.22 M(-22.3%) |
| June 2023 | - | $185.65 M(+23.7%) |
| Mar 2023 | - | $150.12 M(-21.4%) |
| Dec 2022 | $190.87 M(-45.9%) | $190.87 M(-3.6%) |
| Sept 2022 | - | $198.06 M(-20.0%) |
| June 2022 | - | $247.53 M(-15.6%) |
| Mar 2022 | - | $293.31 M(-16.9%) |
| Dec 2021 | $352.92 M(-1.7%) | $352.92 M(+36.1%) |
| Sept 2021 | - | $259.31 M(-12.4%) |
| June 2021 | - | $295.93 M(-9.8%) |
| Mar 2021 | - | $327.99 M(-8.7%) |
| Dec 2020 | $359.08 M(+316.8%) | $359.08 M(-8.4%) |
| Sept 2020 | - | $391.83 M(-6.6%) |
| June 2020 | - | $419.53 M(+111.9%) |
| Mar 2020 | - | $197.94 M(+129.8%) |
| Dec 2019 | $86.15 M | $86.15 M(-21.4%) |
| Sept 2019 | - | $109.57 M(-25.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $146.84 M(-17.0%) |
| Mar 2019 | - | $176.87 M(-14.4%) |
| Dec 2018 | $206.66 M(+32.6%) | $206.66 M(-10.9%) |
| Sept 2018 | - | $232.04 M(+94.4%) |
| June 2018 | - | $119.34 M(-17.0%) |
| Mar 2018 | - | $143.74 M(-7.8%) |
| Dec 2017 | $155.87 M(-1.6%) | $155.87 M(-15.9%) |
| Sept 2017 | - | $185.33 M(-10.7%) |
| June 2017 | - | $207.49 M(+8.6%) |
| Mar 2017 | - | $191.02 M(+20.5%) |
| Dec 2016 | $158.48 M(-32.6%) | $158.48 M(-10.4%) |
| Sept 2016 | - | $176.88 M(-10.7%) |
| June 2016 | - | $198.04 M(-9.5%) |
| Mar 2016 | - | $218.72 M(-12.3%) |
| Dec 2015 | $235.16 M(-12.4%) | - |
| Sept 2015 | - | $249.38 M(+180.1%) |
| June 2015 | $268.32 M(>+9900.0%) | - |
| Dec 2014 | - | $89.02 M(+8989.9%) |
| June 2014 | $979.30 K(-141.4%) | $979.30 K |
| June 2013 | -$2.36 M(+960.0%) | - |
| June 2012 | -$223.00 K | - |
FAQ
- What is Adaptimmune Therapeutics annual working capital?
- What is the all time high annual working capital for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual working capital year-on-year change?
- What is Adaptimmune Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly working capital year-on-year change?
What is Adaptimmune Therapeutics annual working capital?
The current annual working capital of ADAP is $134.76 M
What is the all time high annual working capital for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual working capital is $359.08 M
What is Adaptimmune Therapeutics annual working capital year-on-year change?
Over the past year, ADAP annual working capital has changed by -$56.10 M (-29.39%)
What is Adaptimmune Therapeutics quarterly working capital?
The current quarterly working capital of ADAP is $180.76 M
What is the all time high quarterly working capital for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly working capital is $419.53 M
What is Adaptimmune Therapeutics quarterly working capital year-on-year change?
Over the past year, ADAP quarterly working capital has changed by +$36.53 M (+25.33%)